A cation-π interaction at a phenylalanine residue in the glycine receptor binding site is conserved for different agonists.
Cation-π interactions have been demonstrated to play a major role in agonist-binding in Cys-loop receptors. However, neither the aromatic amino acid contributing to this interaction nor its location is conserved among Cys-loop receptors. Likewise, it is not clear how many different agonists of a given receptor form a cation-π interaction or, if they do, whether it is with the same aromatic amino acid as the major physiological agonist. We demonstrated previously that Phe159 in the glycine receptor (GlyR) α1 subunit forms a strong cation-π interaction with the principal agonist, glycine. In the current study, we investigated whether the lower efficacy agonists of the human GlyR β-alanine and taurine also form cation-π interactions with Phe159. By incorporating a series of unnatural amino acids, we found cation-π interactions between Phe159 and the amino groups of β-alanine and taurine. The strengths of these interactions were significantly weaker than for glycine. Modeling studies suggest that β-alanine and taurine are orientated subtly differently in the binding pocket, with their amino groups further from Phe159 than that of glycine. These data therefore show that similar agonists can have similar but not identical orientations and interactions in the binding pocket and provide a possible explanation for the lower potencies of β-alanine and taurine.
School of Biomedical Sciences, University of Queensland, Brisbane, Queensland, Australia.
Stephan A
SA
Pless
Ariele P
AP
Hanek
Kerry L
KL
Price
Joseph W
JW
Lynch
Henry A
HA
Lester
Dennis A
DA
Dougherty
Sarah C R
SC
Lummis
D000595:Amino Acid Sequence; D000818:Animals; D001665:Binding Sites / Q000502:physiology; D002412:Cations / Q000378:metabolism; D017124:Conserved Sequence; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D010649:Phenylalanine / Q000378:metabolism*; D018009:Receptors, Glycine / Q000819:agonists* / Q000378:metabolism*; D013654:Taurine / Q000378:metabolism*; D014982:Xenopus laevis; D015091:beta-Alanine / Q000378:metabolism*
D002412:Cations; C114561:GLRB protein, human; D018009:Receptors, Glycine; D015091:beta-Alanine; D013654:Taurine; D010649:Phenylalanine
J Biol Chem. 2007 Dec 7;282(49):36057-67
17911099
Neuron. 1992 Sep;9(3):491-6
1326295
Proc Natl Acad Sci U S A. 1996 Oct 1;93(20):10566-71
8855218
Bull N Y Acad Med. 1966 Nov;42(11):996-1006
5232128
J Neurochem. 1999 Nov;73(5):2158-66
10537076
Chem Biol. 2005 Sep;12(9):993-7
16183023
BMC Pharmacol. 2004 Aug 09;4:16
15301692
Curr Opin Chem Biol. 2000 Dec;4(6):645-52
11102869
Nature. 1995 Jan 5;373(6509):37-43
7800037
J Neurosci. 2004 Oct 13;24(41):9097-104
15483128
Nature. 2009 Jan 1;457(7225):111-4
18987633
Mol Pharmacol. 1995 Nov;48(5):919-27
7476923
J Neurochem. 2007 Feb;100(3):758-69
17181559
Chem Rev. 2008 May;108(5):1642-53
18447378
Curr Opin Neurobiol. 2003 Jun;13(3):264-70
12850209
Nature. 1997 Jul 24;388(6640):377-80
9237754
J Physiol. 2003 Jun 1;549(Pt 2):361-74
12679369
J Biol Chem. 2005 May 27;280(21):20476-82
15781467
Proc R Soc Lond B Biol Sci. 1987 Feb 23;230(1258):15-52
2438700
Trends Pharmacol Sci. 2002 Nov;23(11):519-27
12413807
EMBO J. 2009 Oct 7;28(19):3040-51
19696737
J Neurosci. 2007 Jan 24;27(4):886-92
17251430
EMBO J. 1992 Jun;11(6):2025-32
1376243
Br J Pharmacol. 2007 Jul;151(5):666-77
17502851
J Neurosci. 2008 Oct 22;28(43):10937-42
18945901
Biophys J. 2003 Apr;84(4):2338-44
12668442
Nature. 2008 Mar 20;452(7185):375-9
18322461
Proc Natl Acad Sci U S A. 1999 Aug 17;96(17):9459-64
10449714
Nature. 2001 May 17;411(6835):269-76
11357122
Cell Mol Life Sci. 2001 May;58(5-6):760-93
11437237
Nature. 2003 Jun 26;423(6943):949-55
12827192
Philos Trans R Soc Lond B Biol Sci. 2001 Aug 29;356(1412):1121-30
11545694
Biochemistry. 2002 Aug 13;41(32):10262-9
12162741
EMBO J. 1995 Jul 3;14(13):2987-98
7621814
Proc Natl Acad Sci U S A. 1998 Oct 13;95(21):12088-93
9770444
J Physiol. 2001 Sep 15;535(Pt 3):741-55
11559772
Nature. 2009 Jan 1;457(7225):115-8
18987630
Neuron. 2005 Mar 3;45(5):727-39
15748848
Methods Enzymol. 1998;293:504-29
9711626
Neuron. 1995 Jan;14(1):169-75
7826634
J Biol Chem. 2009 Oct 2;284(40):27370-6
19643731
Mol Pharmacol. 1996 Nov;50(5):1401-12
8913372
Science. 1993 Oct 8;262(5131):256-8
8211147
Nature. 2009 Mar 26;458(7237):534-7
19252481
Nature. 2008 Aug 7;454(7205):722-7
18633353
Physiol Rev. 2004 Oct;84(4):1051-95
15383648
Science. 2004 May 7;304(5672):884-7
15131310
J Am Chem Soc. 2003 Jun 11;125(23):6850-1
12783521